Skip to content
Search

Latest Stories

H2-antagonists face supply disruption

The Department of Health and Social Care (DH) has issued supply notification for various strengths of three H2-antagonists- Cimetidine, Famotidine, and Nizatidine.

ProductSupplierAnticipated Resupply dateDetail
Famotidine 20mg tabletsTilomed LaboratoriesOut of stock, resupply mid October 2020
Teva UKOut of stock, resupply w/c 5th October 2020
Famotidine 40mg tabletsTilomed LaboratoriesIn stock
Teva UKOut of stock, resupply w/c 5th October 2020
Cimetidine 200mg tabletsEnnogen PharmaJune 2021Unlicensed supplies have been sourced
Medreichto be confirmed
Cimetidine 400mg tabletsEnnogen PharmaJune 2021
Medreichto be confirmed
Cimetidine 800mg tabletsEnnogen PharmaJune 2021
Medreichto be confirmed
Cimetidine 200mg/5ml oral solutionRosemont Pharmaceuticalsn/aIn stock
Nizatidine 150mg tabletsMylanOut of stock, resupply December 2020
Medreichto be confirmed
RelonchemIn stock
Nizatidine 300mg tablets MylanOut of stock, resupply December 2020
Medreichto be confirmed
RelonchemIn stock

The following specialist importers have confirmed that they can source unlicensed Cimetidine tablets.


  • Alium Medical (200mg, 400mg and 800mg)
  • Mawdsley’s Unlicensed (400mg)

There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for unlicensed Cimetidine (strength) tablets cannot be issued.

If a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Cimetidine (strength) tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.

More For You

Antibiotic prescribing for sore throats in England's pharmacies is twice as high as in Wales

Antibiotic supply rate was 72.7% under England’s Acute Sore Throat Pharmacy First compared to just 29.9% under Wales’ Sore Throat Test and Treat (STTT) scheme in six months.

Getty Images

Sore throat treatment: England pharmacies twice as likely to prescribe antibiotics as Welsh counterparts

A new study has highlighted significant differences in antibiotic use for sore throat treatment between pharmacies in England and Wales, suggesting that incorporating throat swabs to confirm bacterial infections could help reduce “unnecessary antibiotic supply.”

The study, published in the Journal of Antimicrobial Chemotherapy and first reported by The Independent, found that pharmacies in England were twice as likely to prescribe antibiotics for sore throats compared to those in Wales.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less
NPA and IPA urge NHS England to release pharmacy economic analysis immediately

Pharmacy bodies call for transparency on the funding gap amid ongoing contract negotiations.

Getty Images

Pharmacy bodies demand immediate release of economic analysis

The National Pharmacy Association (NPA) and the Independent Pharmacies Association (IPA) have jointly written to NHS England, demanding the immediate release of the independent economic analysis of pharmacy finances commissioned last autumn.

An open letter, signed by the owners of 3,034 pharmacies in England, calls for transparency on the funding gap amid ongoing contract negotiations.

Keep ReadingShow less
Discrimination: Asian and Black patients report lack of trust in primary care providers

Ethnic minority groups had worse experiences in their communication with their GP practice and felt taken less seriously

Getty Images

Survey reveals alarming rates of ethnic discrimination in NHS primary care

A recent survey by the NHS Race and Health Observatory has highlighted a worrying lack of trust in NHS primary care services among Black, Asian, and ethnic minority patients, who reported experiencing “racial or ethnic discrimination.”

Out of 2,680 survey respondents, only 55% reported trusting primary care providers to meet their health needs most or all of the time

Keep ReadingShow less